TSI Group Co., Ltd. (SHA:603262)

Market Cap	9.60B
Revenue (ttm)	1.06B +18.6%
Net Income	154.33M -3.6%
EPS	0.43 -6.6%
Shares Out	400.01M
PE Ratio	55.89
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	986,171
Average Volume	936,605
Open	24.91
Previous Close	24.97
Day's Range	23.93 - 25.01
52-Week Range	23.93 - 51.80
Beta	n/a
RSI	29.91
Earnings Date	Apr 28, 2026

About TSI Group

TSI Group Co., Ltd. engages in the discovery, development, manufacturing, and sale of vitamins and dietary supplements for healthy lifestyles worldwide. It offers vegan glucosamine under the GlucosaGreen brand name; ß-hydroxy ß-methylbutyrate, a nutritional solution under the myHMB brand name; adenosine 5’- triphosphate under the PEAK ATP brand name for body composition and athletic performance; 2-hydroxybenzylamine, a naturally occurring compound to support cellular health; enfinity, a downstream metabolite of caffeine; vitamins and dietary su...

• Industry: Medical - Pharmaceuticals
• Sector: Healthcare
• Founded: 1996
• Employees: 687
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 603262

Financial Performance

In 2024, TSI Group's revenue was 1.00 billion, an increase of 12.33% compared to the previous year's 891.89 million. Earnings were 174.44 million, an increase of 9.02%.